Anixa Biosciences is trading 5.1% up today at $3.49, rebounding from a previous session drop despite a broader market downturn.
- The stock is significantly outperforming the biotech sector, which is down approximately 3%, and the Nasdaq amid a tech-led risk-off mood.
- There are no fresh company-specific catalysts today; the move appears to be a continuation of recent volatility and price-action follow-through from prior trading sessions.